b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30657313</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>03</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>03</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1520-4804</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>62</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>02</Month>\n                        <Day>28</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of medicinal chemistry</Title>\n                <ISOAbbreviation>J. Med. Chem.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-\xce\xb3 Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1837-1858</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jmedchem.8b01296</ELocationID>\n            <Abstract>\n                <AbstractText>An inverse agonist of estrogen-related receptor-\xce\xb3 (ERR\xce\xb3), an orphan nuclear receptor encoded by E srrg, enhances sodium iodide symporter-mediated radioiodine uptake in anaplastic thyroid cancer (ATC) cells, thereby facilitating responsiveness to radioiodine therapy in vitro. We synthesized potent, selective, and orally bioavailable ERR\xce\xb3-inverse agonists and evaluated their activity by analyzing in vitro pharmacology and absorption, distribution, metabolism, excretion, and toxicity profiles. X-ray crystallographic analysis of the ligand and ERR\xce\xb3 complex showed that 35 completely binds to the target protein (PDB 6A6K ). Our results showed improved radioiodine avidity in ATC cells through compound 35-mediated upregulation of iodide-handling genes, leading to enhanced responsiveness to radioiodine therapy in vitro. Importantly, in vivo <sup>124</sup>I-positron emission tomography/computed tomography imaging revealed that 35 increases radioiodine avidity in CAL62 tumors. Collectively, these results demonstrated that 35 can be developed as a promising treatment for ERR\xce\xb3-related cancer in the future.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Kim</LastName>\n                    <ForeName>Jina</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Song</LastName>\n                    <ForeName>Jaeyoung</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ji</LastName>\n                    <ForeName>Hyun Dong</ForeName>\n                    <Initials>HD</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yoo</LastName>\n                    <ForeName>Eun Kyung</ForeName>\n                    <Initials>EK</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Jae-Eon</ForeName>\n                    <Initials>JE</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biomaterials Science, College of Natural Resources and Life Science/Life and Industry Convergence Research Institute , Pusan National University , Pusan 50463 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Sang Bong</ForeName>\n                    <Initials>SB</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Oh</LastName>\n                    <ForeName>Ji Min</ForeName>\n                    <Initials>JM</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Seungmi</ForeName>\n                    <Initials>S</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hwang</LastName>\n                    <ForeName>Ji Sun</ForeName>\n                    <Initials>JS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yoon</LastName>\n                    <ForeName>Heeseok</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kim</LastName>\n                    <ForeName>Dong-Su</ForeName>\n                    <Initials>DS</Initials>\n                    <Identifier Source="ORCID">0000-0003-0388-4633</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Su-Jeong</ForeName>\n                    <Initials>SJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Jeong</LastName>\n                    <ForeName>Minseon</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Sungwoo</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kim</LastName>\n                    <ForeName>Kyung-Hee</ForeName>\n                    <Initials>KH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Choi</LastName>\n                    <ForeName>Hueng-Sik</ForeName>\n                    <Initials>HS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>National Creative Research Initiatives Center for Nuclear Receptor Signals and Hormone Research Center, School of Biological Sciences and Technology , Chonnam National University , Gwangju 61186 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Sang Woo</ForeName>\n                    <Initials>SW</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Park</LastName>\n                    <ForeName>Keun-Gyu</ForeName>\n                    <Initials>KG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, School of Medicine , Kyungpook National University , Daegu 41944 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>In-Kyu</ForeName>\n                    <Initials>IK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, School of Medicine , Kyungpook National University , Daegu 41944 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kim</LastName>\n                    <ForeName>Seong Heon</ForeName>\n                    <Initials>SH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hwang</LastName>\n                    <ForeName>Hayoung</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Jeon</LastName>\n                    <ForeName>Yong Hyun</ForeName>\n                    <Initials>YH</Initials>\n                    <Identifier Source="ORCID">0000-0003-3161-7698</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory Animal Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chin</LastName>\n                    <ForeName>Jungwook</ForeName>\n                    <Initials>J</Initials>\n                    <Identifier Source="ORCID">0000-0001-6060-0508</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cho</LastName>\n                    <ForeName>Sung Jin</ForeName>\n                    <Initials>SJ</Initials>\n                    <Identifier Source="ORCID">0000-0002-4786-8830</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>New Drug Development Center , Daegu-Gyeongbuk Medical Innovation Foundation , Daegu 41061 , South Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>04</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>J Med Chem</MedlineTA>\n            <NlmUniqueID>9716531</NlmUniqueID>\n            <ISSNLinking>0022-2623</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C490917">ESRRG protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D004967">Estrogens</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007457">Iodine Radioisotopes</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000614959">Iodine-124</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000614965">Iodine-131</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D027981">Symporters</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>094ZI81Y45</RegistryNumber>\n                <NameOfSubstance UI="D013629">Tamoxifen</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>4XE5NDT4K1</RegistryNumber>\n                <NameOfSubstance UI="C070626">sodium-iodide symporter</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>\n                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>\n                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D054314" MajorTopicYN="N">Drug Inverse Agonism</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004967" MajorTopicYN="N">Estrogens</DescriptorName>\n                <QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName>\n                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>\n                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007457" MajorTopicYN="N">Iodine Radioisotopes</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D027981" MajorTopicYN="N">Symporters</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013629" MajorTopicYN="N">Tamoxifen</DescriptorName>\n                <QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName>\n                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>\n                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D065646" MajorTopicYN="N">Thyroid Carcinoma, Anaplastic</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013964" MajorTopicYN="N">Thyroid Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>19</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>3</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>19</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30657313</ArticleId>\n            <ArticleId IdType="doi">10.1021/acs.jmedchem.8b01296</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'